Javascript must be enabled to continue!
VARIATIONS IN L‐DOPA ABSORPTION
View through CrossRef
Abstract. In a parkinsonian patient with a weak effect of L‐dopa on the parkinsonian symptoms, unusually high plasma levels of dopa and dopamine sulphate were noticed. The plasma concentrations of tyrosine and phenylalanine were low during the whole observation period. The urinary excretion of dopamine sulphate and the ratio of dopamine sulphate to dopamine in urine were high. The reason for this high ratio of dopamine sulphate to dopamine could not be determined. The disappearance of L‐dopa from plasma after i.v. administration was only slightly reduced. It was concluded that the L‐dopa absorption in this patient was very efficient due to a low dopa decarboxylation in the intestinal organs in spite of a normal decarboxylase activity in other peripheral tissues. Such a selective decrease in the dopa decarboxylation in the intestinal. organs is presumably unusual, but illustrates that very marked individual variations in the L‐dopa metabolism may occur in parkinsonian patients.
Title: VARIATIONS IN L‐DOPA ABSORPTION
Description:
Abstract.
In a parkinsonian patient with a weak effect of L‐dopa on the parkinsonian symptoms, unusually high plasma levels of dopa and dopamine sulphate were noticed.
The plasma concentrations of tyrosine and phenylalanine were low during the whole observation period.
The urinary excretion of dopamine sulphate and the ratio of dopamine sulphate to dopamine in urine were high.
The reason for this high ratio of dopamine sulphate to dopamine could not be determined.
The disappearance of L‐dopa from plasma after i.
v.
administration was only slightly reduced.
It was concluded that the L‐dopa absorption in this patient was very efficient due to a low dopa decarboxylation in the intestinal organs in spite of a normal decarboxylase activity in other peripheral tissues.
Such a selective decrease in the dopa decarboxylation in the intestinal.
organs is presumably unusual, but illustrates that very marked individual variations in the L‐dopa metabolism may occur in parkinsonian patients.
Related Results
d‐DOPA IS UNIDIRECTIONALLY CONVERTED TOl‐DOPA BYd‐AMINO ACID OXIDASE, FOLLOWED BY DOPA TRANSAMINASE
d‐DOPA IS UNIDIRECTIONALLY CONVERTED TOl‐DOPA BYd‐AMINO ACID OXIDASE, FOLLOWED BY DOPA TRANSAMINASE
SUMMARYMany studies have shown that administration ofd‐3, 4‐dihydroxyphenylalanine (d‐dopa) produces contralateral rotation in hemi‐parkinsonian animals comparable tol‐dopa, with l...
Effect of the Dopa Decarboxylase Inhibitor MK-486 on L-dopa-Induced Inhibition of Prolactin Secretion: Evidence for CNS Participation in the L-dopa Effects
Effect of the Dopa Decarboxylase Inhibitor MK-486 on L-dopa-Induced Inhibition of Prolactin Secretion: Evidence for CNS Participation in the L-dopa Effects
The present studies were performed in order to determine whether the inhibition of prolactin (Prl) secretion which follows the systemic administration of L-dopa and its conversion ...
L-Dopa Treatment in Parkinson’s Disease
L-Dopa Treatment in Parkinson’s Disease
Double-blind and non-blind therapeutic trials of orally administered L-Dopa in the long-term treatment of Parkinsonism were carried out with 126 patients. For correlative studies t...
The Design and Evaluation of an l-Dopa–Lazabemide Prodrug for the Treatment of Parkinson’s Disease
The Design and Evaluation of an l-Dopa–Lazabemide Prodrug for the Treatment of Parkinson’s Disease
l-Dopa, the metabolic precursor of dopamine, is the treatment of choice for the symptomatic relief of the advanced stages of Parkinson’s disease. The oral bioavailability of l-dopa...
Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice
Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice
ABSTRACTBackgroundDyskinesias are a disabling motor complication that arises with prolonged l‐dopa treatment. Studies using D1 receptor drugs and genetically modified mice suggest ...
Doxycycline, an anti-inflammatory agent, alleviates dyskinesia induced by L-DOPA in Parkinsonian rats
Doxycycline, an anti-inflammatory agent, alleviates dyskinesia induced by L-DOPA in Parkinsonian rats
Background and Purpose L-DOPA induced dyskinesia is a debilitating side
effect of treating Parkinson’s disease with L-DOPA. There is a need to
discover a treatment that has the sam...
Levodopa Inhibits the Development of Form‐Deprivation Myopia in Guinea Pigs
Levodopa Inhibits the Development of Form‐Deprivation Myopia in Guinea Pigs
ABSTRACT
Purpose.
It has been shown that visual deprivation leads to a myopic refractive error and...
Variability of L-Dopa and its association with morphological growth and yield traits of Mucuna pruriens (L.) germplasm
Variability of L-Dopa and its association with morphological growth and yield traits of Mucuna pruriens (L.) germplasm
Fifty eight germplasm of Mucuna was analysed for L-Dopa using ultra high performance liquid Chromatography. L-Dopa ranges from 2.94% in IC 332432 to 6.91% in IIHR MP62-1. Low L-Dop...

